Bridging the Global Divide in Colorectal Cancer Care: Findings from the "Global Cancer Movement – Challenging the Status Quo in Colorectal Cancer" Congress

2025

Full text Open access: Hybrid Metadata (CSL-JSON)
DOI 10.69690/odmj-001-1015-5792
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Colorectal cancer (CRC) is a major and growing global health challenge, marked by stark disparities in incidence, mortality, and access to care between high-income countries (HICs) and low- and middle-income countries (LMICs). The “Global Cancer Movement: Challenging the Status Quo in Colorectal Cancer” Congress, a three-day virtual event, brought together international experts to examine these disparities and develop strategies to improve CRC outcomes worldwide. This paper synthesizes the congress’s key insights, assessing challenges in CRC prevention, diagnosis, and treatment across diverse settings and highlighting priority areas for action. The rising incidence of early-age onset CRC (EAOCRC) adds further complexity, demanding urgent research and tailored approaches. Addressing the global CRC burden requires investment in data systems, equitable access to screening and early diagnosis, context-specific therapeutic innovation, workforce and infrastructure development, and targeted EAOCRC strategies. Civil-society actors, particularly national NGOs, are instrumental in co-leading early detection and navigation initiatives with primary care and in ensuring uptake and follow-up at the community level. Strengthened global partnerships and cohesive policies are essential to closing the care gap and reducing the toll of this preventable and treatable disease.